BN Business News
Add your company to Business Communicator →

Zdrowie i gospodarka · 28/06/2019

FDA Announces Draft Guidance for Heart Failure Drug Development

The FDA is releasing a draft guidance that clarifies the endpoints for drug development to treat heart failure, including the potential for approving drugs that show improvement in symptoms or physical function without a significant impact on survival or hospitalization.

Source: Federal Register — Food and Drug AdministrationOpen original release →